MedTrace Logo

Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based Nutraceutical

NCT05000541 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 259

Last updated 2023-11-07

No results posted yet for this study

Summary

The objective of the present multinational, multicentre, prospective, scientific study is to confirm that prescription of a low-dose red yeast-based nutraceutical.

Conditions

Sponsors & Collaborators

  • Mylan Österreich GmbH

    collaborator UNKNOWN

  • Mylan Germany GmbH

    collaborator UNKNOWN

  • Mylan Healthcare Sp. z o.o.

    collaborator UNKNOWN

  • Mylan Inc.

    lead INDUSTRY

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-08
Primary Completion
2023-10-31
Completion
2023-10-31

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05000541 on ClinicalTrials.gov